SI-BONE, Inc. (NASDAQ: SIBN) is a Healthcare company (Medical - Devices) with a market capitalization of $1.0B. The Maz Rating grades it against the other companies in its sector.
SI-BONE, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $23.16, SI-BONE, Inc. trades at 4.7x sales and 5.6x book value. Over the last twelve months it generated about $221M of revenue and a net loss of $14M. It runs a gross margin of 79.4%, an operating margin of -7.6% and a net margin of -6.2%. It shows return on equity of -7.6%, return on invested capital of -7.3% and a free cash flow yield of -0.4%. On the balance sheet: a debt-to-equity ratio of 0.23 and a current ratio of 7.58. Over the past 52 weeks the share price ranged from $11.48 to $25.92, with a beta of 0.64.
SI-BONE, Inc. does not currently pay a dividend.
10 Wall Street analyst ratings cover the stock: 10 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.